Apogee Therapeutics Share Price Today (NASDAQ: APGE)

Name: Apogee Therapeutics Share Price (NASDAQ: APGE) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Apogee Therapeutics share price is $43.76 & ₹3,751.22 as on 27 Jun 2025, 01.30 'hrs' IST

$43.76

▲

0.77

(1.79%)

Market is closed - opens 7 PM, 27 Jun 2025

View live Apogee Therapeutics share price in Dollar and Rupees. Guide to invest in Apogee Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Apogee Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Apogee Therapeutics share price movements

Today's Low: $42.76
Today's High: $43.83
$43.76
2.29%
Downside
Day's Volatility :2.44%
Upside
0.16%
52 Weeks Low: $26.20
52 Weeks High: $63.50
$43.76
40.13%
Downside
52 Weeks Volatility :58.74%
Upside
31.09%

Apogee Therapeutics (APGE) Returns

Period	Apogee Therapeutics
3 Months	8.26%
6 Months	-6.13%
1 Year	7.63%
3 Years	102.54%

Apogee Therapeutics (APGE) Key Statistics

in dollars & INR

Previous Close	$42.99
Open	$42.95
Today's High	$43.83
Today's Low	$42.76
Market Capitalization	$2.5B
Today's Volume	$411.5K
52 Week High	$63.5
52 Week Low	$26.2
Revenue TTM	$0.0
EBITDA	$-241.4M
Earnings Per Share (EPS)	$-3.61
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-27.85%

How to invest in Apogee Therapeutics Stock (APGE) from India?

It is very easy for Indian residents to invest directly in Apogee Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Apogee Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Apogee Therapeutics or APGE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Apogee Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Apogee Therapeutics shares which would translate to 0.020 fractional shares of Apogee Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Apogee Therapeutics, in just a few clicks!

Returns in Apogee Therapeutics (APGE) for Indian investors in Rupees

The Apogee Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Apogee Therapeutics investment value today

Current value as on today

₹1,12,276

Returns

₹12,276

(+12.28%)

Returns from Apogee Therapeutics Stock

₹9,537 (+9.54%)

Dollar Returns*

₹2,739 (+2.74%)

Indian investors sentiment towards Apogee Therapeutics (APGE)

20%

Period: May 27, 2025 to Jun 26, 2025. Change in 30 Days versus previous period

Search interest for Apogee Therapeutics Stock from India on INDmoney has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Apogee Therapeutics

Rating

Trend

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Apogee Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Apogee Therapeutics Stock (APGE)

What analysts predicted

Upside of 114.52%

Target:

$93.88

Current:

$43.76

Apogee Therapeutics Technicals Summary

Sell

Neutral

Buy

Apogee Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Apogee Therapeutics Dividend announcements

Apogee Therapeutics Earnings
Apogee Therapeutics’s price-to-earnings ratio stands at None

About Apogee Therapeutics

Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications. The company develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for the treatment of AD, which is in phase 2 clinical trials; and for the treatment of asthma and EoE which is in phase 1 clinical trial. It also develops APG279 that is in preclinical stage for the treatment of AD; APG990, an SQ extended half-life mAb for the treatment of AD; APG333, a human mAb against thymic stromal lymphopoietin for the treatment of asthma and COPD; and APG808, an SQ extended half-life mAb targeting IL-4Ra for the treatment of Type 2 allergic diseases. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.

Organization	Apogee Therapeutics
Employees	196
CEO	Dr. Michael Thomas Henderson M.D.
Industry	Miscellaneous

Management People of Apogee Therapeutics

Name	Title
Dr. Michael Thomas Henderson M.D.	CEO & Director
Ms. Jane Pritchett V. Henderson	Chief Financial Officer
Dr. Carl Linden Dambkowski M.D.	Chief Medical Officer
Ms. Noel Kurdi	Vice President of Investor Relations
Mr. Matthew Batters J.D.	Chief Legal Officer & Corporate Secretary
Ms. Emily Cox	SVP & Head of People
Dr. Rebecca Dabora Ph.D.	Chief Development Officer
Ms. Wendy Aspden-Curran	Senior Vice President of Clinical Operations
Dr. Drew Badger Ph.D.	Senior VP and Head of Regulatory Affairs & Toxicology
Ms. Monica Forbes	Senior Vice President of Finance

Important FAQs about investing in APGE Stock from India :

Can Indians buy Apogee Therapeutics shares?

Yes, Indians can invest in the Apogee Therapeutics (APGE) from India.

With INDmoney, you can buy Apogee Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Apogee Therapeutics at zero transaction cost.

How can I buy Apogee Therapeutics shares from India?

It is very easy to buy Apogee Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Apogee Therapeutics (APGE) be purchased?

Yes, you can buy fractional shares of Apogee Therapeutics with INDmoney app.

What are the documents required to start investing in Apogee Therapeutics stocks?

To start investing in Apogee Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Apogee Therapeutics share price today?

Apogee Therapeutics share price today stands at $43.76, Open: $42.95 ; Previous Close: $42.99 ; High: $43.83 ; Low: $42.76 ; 52 Week High: $63.50 ; 52 Week Low: $26.20.

The stock opens at $42.95, after a closing price of $42.99. The stock reached a daily high of $43.83 and a low of $42.76, with a 52-week high of $63.50 and a 52-week low of $26.20.